{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:55:02Z","timestamp":1785192902944,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.addbeh.2025.108454","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:23:14Z","timestamp":1755037394000},"page":"108454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US"],"prefix":"10.1016","volume":"170","author":[{"given":"Samantha M.","family":"Ross-Cypcar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-4782","authenticated-orcid":false,"given":"Justin A.","family":"Haegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2025.108454_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52965\/001c.127794","article-title":"The psych behind psychedelics: Exploring hallucinogen use as a marker of untreated mental health disorders","volume":"13","author":"Ahmed","year":"2025","journal-title":"Health Psychology Research"},{"key":"10.1016\/j.addbeh.2025.108454_b0010","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013).Diagnostic and statistical manual of mental disorders(5th ed.). Doi: 10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.addbeh.2025.108454_b0015","unstructured":"Center for Behavioral Health Statistics and Quality. (2023). 2022 National Survey on Drug Use and Health (NSDUH): Methodological summary and definitions. Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/data\/report\/2022- methodologicalsummary-and-definitions."},{"issue":"1","key":"10.1016\/j.addbeh.2025.108454_b0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/19315864.2024.2397403","article-title":"Suicidality and intellectual disability: A systematic review","volume":"18","author":"Chan","year":"2025","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"issue":"11","key":"10.1016\/j.addbeh.2025.108454_b0025","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.addbeh.2025.108454_b0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.addbeh.2025.108454_b0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/RMHP.S300656","article-title":"The use of classic hallucinogens\/psychedelics in a therapeutic context: Healthcare policy opportunities and challenges","volume":"14","author":"Dos Santos","year":"2021","journal-title":"Risk Management & Healthcare Policy"},{"key":"10.1016\/j.addbeh.2025.108454_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00943","article-title":"Therapeutic use of LSD in psychiatry: A systematic review of randomized-controlled clinical trials","volume":"10","author":"Fuentes","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.addbeh.2025.108454_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.abrep.2019.100228","article-title":"Hallucinogen use is associated with mental health and addictive problems and impulsivity in university studies","volume":"10","author":"Grant","year":"2019","journal-title":"Addictive Behaviors Reports"},{"key":"10.1016\/j.addbeh.2025.108454_b0050","series-title":"Handbook of medical hallucinogens","year":"2021"},{"key":"10.1016\/j.addbeh.2025.108454_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2025.108222","article-title":"Illicit Drug Use among Adolescents and Young adults with Impairments in the US: A Cross-Sectional Analysis of the National Survey on Drug Use and Health","volume":"191","author":"Haegele","year":"2025","journal-title":"Preventative Medicine"},{"issue":"1","key":"10.1016\/j.addbeh.2025.108454_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/ADM.0000000000001031","article-title":"Opioid use behaviors among people with disability in the United States: An analysis of the National Survey on Drug Use and Health","volume":"17","author":"Hong","year":"2023","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.addbeh.2025.108454_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2024-105532","article-title":"Psilocybin and chronic neuropathic pain: A systematic review","author":"Jevotovsky","year":"2024","journal-title":"Regional Anesthesia & Pain Medicine."},{"issue":"11","key":"10.1016\/j.addbeh.2025.108454_b0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The prevalence of chronic pain in United States adults: Results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"The Journal of Pain"},{"issue":"3","key":"10.1016\/j.addbeh.2025.108454_b0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/psymed.2023.0023","article-title":"Balancing therapeutic efficacy and safety of MDMA and novel MDXX analogues as novel treatments for autism spectrum disorder","volume":"1","author":"Kaur","year":"2023","journal-title":"Psychedelic Medicine"},{"issue":"S1","key":"10.1016\/j.addbeh.2025.108454_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mpr.310","article-title":"Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO World Mental Health (WMH) survey initiative","volume":"19","author":"Kessler","year":"2010","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"10.1016\/j.addbeh.2025.108454_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749068","article-title":"Evaluating the potential use of serotonergic psychedelics in autism spectrum disorder","volume":"12","author":"Markopoulos","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.addbeh.2025.108454_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpsychires.2022.07.014","article-title":"Association between functional disability type and suicide-related outcomes among US adults with disabilities in the National Survey on Drug Use and Health, 2015\u20132019","volume":"153","author":"Marlow","year":"2022","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.addbeh.2025.108454_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.914458","article-title":"Physical disability and psychedelic therapies: An agenda for inclusive research and practice","volume":"13","author":"Mintz","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.addbeh.2025.108454_b0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annemergmed.2023.11.003","article-title":"The rise of psychedelic drug use associated with legalization\/decriminalization: An assessment with the nonmedical use of prescription drugs survey","volume":"83","author":"Monte","year":"2024","journal-title":"Annals of Emergency Medicine"},{"issue":"6","key":"10.1016\/j.addbeh.2025.108454_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/papr.13220","article-title":"Associations between chronic pain, anxiety, and depression among adults in the United States","volume":"23","author":"Mullins","year":"2023","journal-title":"Pain Practice"},{"issue":"5","key":"10.1016\/j.addbeh.2025.108454_b0110","first-page":"500","article-title":"Microdosing psychedelics: Current evidence from controlled studies","volume":"9","author":"Murphy","year":"2024","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.addbeh.2025.108454_b0115","first-page":"1","article-title":"I am #actuallyautistic, hear me tweet: The autist-topoi of autistic activists on Twitter","volume":"31","author":"Osorio","year":"2020","journal-title":"Enculturation"},{"issue":"1","key":"10.1016\/j.addbeh.2025.108454_b0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881120953994","article-title":"Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention","volume":"36","author":"Petranker","year":"2022","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2025.108454_b0125","doi-asserted-by":"crossref","first-page":"22479","DOI":"10.1038\/s41598-021-01811-4","article-title":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","volume":"11","author":"Rootman","year":"2021","journal-title":"Scientific Reports"},{"issue":"B","key":"10.1016\/j.addbeh.2025.108454_b0130","article-title":"Toward a typology of hallucinogen users in the United States","volume":"229","author":"Salas-Wright","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2025.108454_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.addbeh.2025.108454_b0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11195-024-09870-x","article-title":"Narratives of personal health and sexual education experiences of emerging adults with disabilities","volume":"42","author":"Toman","year":"2024","journal-title":"Sexuality and Disability"},{"key":"10.1016\/j.addbeh.2025.108454_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107343","article-title":"Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults","volume":"132","author":"Yang","year":"2022","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.addbeh.2025.108454_b0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.1653","article-title":"State cannabis and psychedelic legislation and microdosing interest in the US","volume":"5","author":"Yang","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.addbeh.2025.108454_b0155","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The impact of ayahuasca on suicidality: Results from a randomized controlled trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Frontiers in Pharmacology"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460325002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460325002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:27:53Z","timestamp":1756294073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460325002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":31,"alternative-id":["S0306460325002151"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2025.108454","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2025.108454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108454"}}